|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 3 January 2006
doi: 10.1242/jcs.02732
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |


Department of Biochemistry and Molecular Biology, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA
Author for correspondence (e-mail: skachw{at}ohsu.edu)
Accepted 5 October 2005
The 26S proteasome is the primary protease responsible for degrading misfolded membrane proteins in the endoplasmic reticulum. Here we examine the specific role of ß subunit function on polypeptide cleavage and membrane release of CFTR, a prototypical ER-associated degradation substrate with 12 transmembrane segments. In the presence of ATP, cytosol and fully active proteasomes, CFTR was rapidly degraded and released into the cytosol solely in the form of trichloroacetic acid (TCA)-soluble peptide fragments. Inhibition of proteasome ß subunits markedly decreased CFTR degradation but surprisingly, had relatively minor effects on membrane extraction and release. As a result, large TCA-insoluble degradation intermediates derived from multiple CFTR domains accumulated in the cytosol where they remained stably bound to inhibited proteasomes. Production of TCA-insoluble fragments varied for different proteasome inhibitors and correlated inversely with the cumulative proteolytic activities of ß1, ß2 and ß5 subunits. By contrast, ATPase inhibition decreased CFTR release but had no effect on the TCA solubility of the released fragments. Our results indicate that the physiologic balance between membrane extraction and peptide cleavage is maintained by excess proteolytic capacity of the 20S subunit. Active site inhibitors reduce this capacity, uncouple ATPase and peptidase activities, and generate cytosolic degradation intermediates by allowing the rate of unfolding to exceed the rate of polypeptide cleavage.
Key words: CFTR, ER-associated degradation, Polytopic proteins, Cystic fibrosis, ER dislocation, Proteasome inhibitors, p97
This article has been cited by other articles:
![]() |
E. A. Fisher, L. R. Lapierre, R. D. Junkins, and R. S. McLeod The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway J. Lipid Res., October 1, 2008; 49(10): 2149 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shibatani, E. J. Carlson, F. Larabee, A. L. McCormack, K. Fruh, and W. R. Skach Global Organization and Function of Mammalian Cytosolic Proteasome Pools: Implications for PA28 and 19S Regulatory Complexes Mol. Biol. Cell, December 1, 2006; 17(12): 4962 - 4971. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vij, S. Fang, and P. L. Zeitlin Selective Inhibition of Endoplasmic Reticulum-associated Degradation Rescues {Delta}F508-Cystic Fibrosis Transmembrane Regulator and Suppresses Interleukin-8 Levels: THERAPEUTIC IMPLICATIONS J. Biol. Chem., June 23, 2006; 281(25): 17369 - 17378. [Abstract] [Full Text] [PDF] |
||||